GREY:ATBPF - Post by User
Post by
Duster340on Oct 05, 2023 10:08am
159 Views
Post# 35670881
45 cent entry point may be gone
45 cent entry point may be gonei think the selling has dried up, smart investors know with every passing day is 1 day closer to go time, and are no longer willing to flip shares for small profits. and then you get investors like davgro and benedictus sniffing around and sensing that they may miss the bottom and trying to spread fear because they need time to come up with the funds to get in. catalyst is on the way.
“With tablets in hand, we’re excited to be approaching several near-term catalysts,” commented Dan Legault, Antibe’s CEO. “We’ll kick off our otenaproxesul clinical program in the fall with a short PK/PD study to confirm liver safety and inform the doses for the Phase II trial, which is slated to start in the first quarter of 2024. Top-line Phase II data are expected late next spring – positive results would set the stage for an End of Phase 2 meeting with the FDA later in 2024. All of this reflects a tremendous behind-the-scenes effort by our scientific, manufacturing and regulatory teams, supported by our global manufacturing partner. The opportunity to capture share in a market roiled by the opioid epidemic has never been greater.”